Dr. Steven E. Mccormack, MD
Hematology & Oncology (Hematology & Oncology Physician)
640 Jackson St, Healthpartners Regions Specialty Clinics - Mc 11503f
St. Paul, MN 55101
- Medicare participating
At a glance
- Medical school
- University of North Dakota School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 159
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of North Dakota School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MN license 53949 · WI license 56010-20
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Regions Hospital Saint PAul, MN
- Lakeview Memorial Hospital Stillwater, MN
- Hudson Hospital Hudson, WI
- Amery Hospital & Clinic Amery, WI
- Westfields Hospital and Clinic New Richmond, WI
Medical groups
- Group Health Inc (1,638 clinicians)
- Westfields Hospital Inc (108 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 159
- Services billed
- 704
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 108 | 76 |
| Established patient office or other outpatient visit, 40-54 minutes | 99 | 38 |
| Insertion of needle into vein for collection of blood sample | 82 | 40 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 69 | 35 |
| Blood creatinine level | 30 | 25 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 24 |
| Established patient office or other outpatient visit, 20-29 minutes | 17 | 16 |
| New patient office or other outpatient visit, 60-74 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in St. PAul, MN | 156 |
| Oxycodone Hcl Other prescribers in St. PAul, MN | 86 |
| Dexamethasone Other prescribers in St. PAul, MN | 67 |
| Letrozole Other prescribers in St. PAul, MN | 56 |
| Olanzapine Other prescribers in St. PAul, MN | 51 |
| Morphine Sulfate Er (morphine sulfate) Other prescribers in St. PAul, MN | 44 |
| Prochlorperazine Maleate Other prescribers in St. PAul, MN | 43 |
| Ondansetron Hcl Other prescribers in St. PAul, MN | 41 |
| Imbruvica (ibrutinib) | 36 |
| Gabapentin Other prescribers in St. PAul, MN | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,691 in research payments for these studies, mostly to the institutions running them.
- Encorafenibbinimetinib master protocol an openlabel continuation study for participants continuing from encorafenibbinimetinib clinical studies
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.